Inventor · disambiguated record
Eiji Kawaminami
Also filed as: KAWAMINAMI EIJI
12 granted patents·6 pending applications·190 citations·filing 1992–2025
91Inventor score
Top patents by PatentIndex Score
18 records- 0187US7709519B2Benzimidazolylidene propane-1,3 dione derivative or salt thereofASTELLAS PHARMA INC·Filed 2005·Granted May 4, 2010·13 cites·21 claims
- 0286US7960562B2Propane-1,3-dione derivative or salt thereofASTELLAS PHARMA INC·Filed 2006·Granted Jun 14, 2011·14 cites·19 claims
- 0386US6960591B2Propane-1,3-dione derivativeYAMANOUCHI PHARMA CO LTD·Filed 2001·Granted Nov 1, 2005·25 cites·6 claims
- 0485US7569688B2Propane-1, 3-dione derivativeASTELLAS PHARMA INC·Filed 2005·Granted Aug 4, 2009·8 cites·39 claims
- 0585US6673799B1Cyanophenyl derivativeYAMANOUCHI PHARMA CO LTD·Filed 1999·Granted Jan 6, 2004·68 cites·7 claims
- 0682US5538976ASubstituted tertiary amino compound or salt thereofYAMANOUCHI PHARMA CO LTD·Filed 1993·Granted Jul 23, 1996·27 cites·11 claims
- 0781US5674886ATriazolylated teritiary amine compound or salt thereofYAMANOUCHI PHARMA CO LTD·Filed 1992·Granted Oct 7, 1997·24 cites·10 claims
- 0874US8076367B2Benzimidazolylidene propane-1,3-dione derivative or salt thereofHIRANO MASAAKI·Filed 2010·Granted Dec 13, 2011·3 cites·8 claims
- 0967US2025340561A1Quinazoline compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2025·Application pending·0 cites
- 1064US12384794B2Quinazoline compound for inducing degradation of G12D mutant KRAS proteinASTELLAS PHARMA INC·Filed 2022·Granted Aug 12, 2025·0 cites·37 claims
- 1163US5807880AAzole derivative and pharmaceutical composition thereofYAMANOUCHI PHARMA CO LTD·Filed 1994·Granted Sep 15, 1998·8 cites·7 claims
- 1263US2025145631A1Heterocyclic compound acting on g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 1362US2025388569A1Heterocyclic compound for inhibiting and/or inducing degradation of kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 1460US2025206751A1Heterocyclic compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 1556US8815920B2Substituted amide compoundASTELLAS PHARMA INC·Filed 2013·Granted Aug 26, 2014·0 cites·5 claims
- 1655US2024150366A14-aminoquinazoline compoundASTELLAS PHARMA INC·Filed 2022·Application pending·0 cites
- 1749US2004010037A1Cyanophenyl derivativeYAMANOUCHI PHARMA CO LTD·Filed 2003·Application pending·0 cites
- 1838US8669246B2Substituted amide compoundKAWAMINAMI EIJI·Filed 2010·Granted Mar 11, 2014·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Eiji Kawaminami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →